Treatment with immune checkpoint inhibitors (ICIs) and the occurrence of colitis among patients with melanoma in the United States

被引：0
|
作者：
Pan, Xianying
Verma, Devashish
Zhang, Jiayin
Pathak, Raminder
Monda, Stefano
Ma, Xiaomei
机构：
来源：
CANCER RESEARCH | 2023年 / 83卷 / 07期
关键词：
D O I：
10.1158/1538-7445.AM2023-736
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
736
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Combination therapy with immune checkpoint inhibitors (ICIs); a new frontier
    Somayeh Vafaei
    Angelina O. Zekiy
    Ramadhan Ado Khanamir
    Burhan Abdullah Zaman
    Arman Ghayourvahdat
    Hannaneh Azimizonuzi
    Majid Zamani
    Cancer Cell International, 22
  • [42] Evaluation of colitis induced by immune-checkpoint inhibitors therapy in melanoma patients by an overall grading scale
    Nguyen, Trang L.
    Tew, Alice
    Kirton, Laura
    Steven, Neil
    JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2024,
  • [43] How have immune checkpoint inhibitors transformed melanoma treatment?
    Schmitt, Andreas Michael
    Larkin, James
    TRENDS IN UROLOGY & MENS HEALTH, 2023, 14 (03) : 26 - 30
  • [44] Characterization of immune related hepatitis (irH) from immune checkpoint inhibitors (ICIs).
    Cohen, Justine Vanessa
    Misdraji, Joseph
    Dougan, Michael
    Fadden, Riley
    Rubin, Krista M.
    Lawless, Aleigha
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [45] Biomarkers for immune Checkpoint inhibitors in Melanoma
    Kitano, Shigehisa
    Nakayama, Takayuki
    Yamashita, Makiko
    FRONTIERS IN ONCOLOGY, 2018, 8
  • [46] Surgery in patients with metastatic melanoma treated with immune checkpoint inhibitors
    Janssen, Josephine C.
    Huibers, Anne E.
    Grunhagen, Dirk J.
    Bagge, Roger Olofsson
    SCANDINAVIAN JOURNAL OF SURGERY, 2025,
  • [47] Recurrent Pneumonitis in Patients with Melanoma Treated with Immune Checkpoint Inhibitors
    Asher, Nethanel
    Marom, Edith M.
    Ben-Betzalel, Guy
    Baruch, Erez Nissim
    Steinberg-Silman, Yael
    Schachter, Jacob
    Shapira-Frommer, Ronnie
    Markel, Gal
    ONCOLOGIST, 2019, 24 (05): : 640 - 647
  • [48] Association of gastric acid suppression with efficacy of immune checkpoint inhibitors (ICIs) in advanced cancer patients
    Izawa, Naoki
    Shiokawa, Hisae
    Onuki, Risa
    Hamaji, Koki
    Furuya, Naoki
    Ohashi, Hiroyuki
    Nishi, Tomohiro
    Kasugai, Shigeru
    Arai, Hiroyuki
    Doi, Ayako
    Horie, Yoshiki
    Hirakawa, Mami
    Mizukami, Takuro
    Ogura, Takashi
    Tsuda, Takashi
    Sunakawa, Yu
    Nakajima, Takako
    ANNALS OF ONCOLOGY, 2019, 30
  • [49] Real world outcomes of immune-related adverse events (irAEs) among patients receiving immune checkpoint inhibitors (ICIs) in hospital settings
    George, S.
    Zheng, Y.
    Kim, R.
    Yu, T.
    Dreyfus, J.
    Gayle, J. A.
    Wassel, C.
    Phatak, H.
    ANNALS OF ONCOLOGY, 2019, 30 : 522 - 522
  • [50] Inpatient and ED Use Among Melanoma and Lung Cancer Patients Receiving Immune Checkpoint Inhibitors
    Tay, Djin L.
    Dubose, Kline
    Meeks, Huong
    Guo, Jia-Wen
    Feldner, Katie
    Alekhina, Natalya
    Sheng, Xiaoming
    Chipman, Jonathan
    Ellington, Lee
    Hashibe, Mia
    JOURNAL OF PAIN AND SYMPTOM MANAGEMENT, 2024, 67 (05) : E826 - E827
12345